Robert J. Cluxton

626 total citations
25 papers, 459 citations indexed

About

Robert J. Cluxton is a scholar working on Pulmonary and Respiratory Medicine, Pharmacology and Physiology. According to data from OpenAlex, Robert J. Cluxton has authored 25 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Pharmacology and 4 papers in Physiology. Recurrent topics in Robert J. Cluxton's work include Asthma and respiratory diseases (4 papers), Gastroesophageal reflux and treatments (2 papers) and Poisoning and overdose treatments (2 papers). Robert J. Cluxton is often cited by papers focused on Asthma and respiratory diseases (4 papers), Gastroesophageal reflux and treatments (2 papers) and Poisoning and overdose treatments (2 papers). Robert J. Cluxton collaborates with scholars based in United States. Robert J. Cluxton's co-authors include Pamela C. Heaton, Raymond Jang, Jeff J. Guo, Charles J. Moomaw, Matthew J. Everly, Charles J. Moomaw, Wei Pan, Andy McCracken, Theresa I. Shireman and Joseph A. Johnston and has published in prestigious journals such as Journal of the American Geriatrics Society, Journal of Adolescent Health and The Journal of Clinical Pharmacology.

In The Last Decade

Robert J. Cluxton

24 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert J. Cluxton United States 11 95 85 77 67 64 25 459
Lillian Mørch Jørgensen Denmark 13 56 0.6× 210 2.5× 64 0.8× 68 1.0× 55 0.9× 27 710
J. Daniel Robinson United States 9 42 0.4× 36 0.4× 50 0.6× 38 0.6× 22 0.3× 38 384
Marie Ludlow Australia 10 96 1.0× 27 0.3× 92 1.2× 49 0.7× 75 1.2× 16 558
T J Thom United States 9 302 3.2× 78 0.9× 99 1.3× 76 1.1× 35 0.5× 11 635
Arsenio H.P. Paes Netherlands 10 286 3.0× 35 0.4× 51 0.7× 56 0.8× 102 1.6× 14 830
S Burrows-Hudson United States 7 81 0.9× 26 0.3× 78 1.0× 32 0.5× 130 2.0× 19 574
Patricia R. Wigle United States 13 82 0.9× 62 0.7× 31 0.4× 49 0.7× 28 0.4× 39 422
Michael Lykens United States 8 51 0.5× 122 1.4× 45 0.6× 192 2.9× 26 0.4× 13 501
Simon Towler Australia 18 80 0.8× 62 0.7× 92 1.2× 64 1.0× 32 0.5× 22 1.0k
Mariana Martins Gonzaga do Nascimento Brazil 12 74 0.8× 57 0.7× 90 1.2× 34 0.5× 74 1.2× 86 564

Countries citing papers authored by Robert J. Cluxton

Since Specialization
Citations

This map shows the geographic impact of Robert J. Cluxton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Cluxton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Cluxton more than expected).

Fields of papers citing papers by Robert J. Cluxton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Cluxton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Cluxton. The network helps show where Robert J. Cluxton may publish in the future.

Co-authorship network of co-authors of Robert J. Cluxton

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Cluxton. A scholar is included among the top collaborators of Robert J. Cluxton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Cluxton. Robert J. Cluxton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buring, Shauna M., et al.. (2012). A Pharmacoeconomics and Formulary Management Collaborative Project to Teach Decision Analysis Principles. American Journal of Pharmaceutical Education. 76(6). 115–115. 6 indexed citations
2.
Warshaw, Gregg, et al.. (2010). Community Physician Education in Geriatrics: Applying the Assessing Care of Vulnerable Elders Model with a Multisite Primary Care Group. Journal of the American Geriatrics Society. 58(9). 1780–1785. 6 indexed citations
3.
Heaton, Pamela C., Jeff J. Guo, Richard Hornung, et al.. (2006). Analysis of the Effectiveness and Cost Benefit of Leukotriene Modifiers in Adults With Asthma in the Ohio Medicaid Population. Journal of Managed Care Pharmacy. 12(1). 33–42. 10 indexed citations
4.
Jang, Raymond, et al.. (2005). Impact of school-based health centers on children with asthma. Journal of Adolescent Health. 37(4). 266–274. 71 indexed citations
5.
Guo, Jeff J., Raymond Jang, Anthony Louder, & Robert J. Cluxton. (2005). Acute Pancreatitis Associated with Different Combination Therapies in Patients Infected with Human Immunodeficiency Virus. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(8). 1044–1054. 27 indexed citations
6.
Everly, Matthew J., Pamela C. Heaton, & Robert J. Cluxton. (2004). β-Blocker Underuse in Secondary Prevention of Myocardial Infarction. Annals of Pharmacotherapy. 38(2). 286–293. 41 indexed citations
7.
Cluxton, Robert J., Zili Li, Pamela C. Heaton, et al.. (2004). Impact of regulatory labeling for troglitazone and rosiglitazone on hepatic enzyme monitoring compliance: findings from the state of Ohio medicaid program. Pharmacoepidemiology and Drug Safety. 14(1). 1–9. 36 indexed citations
8.
Guo, Jeff J., Robert L. Ludke, Pamela C. Heaton, et al.. (2004). Characteristics and risk factors associated with high-cost Medicaid recipients.. PubMed. 17(10). 20–7. 3 indexed citations
9.
Guo, Jeff J., et al.. (2004). Price and Market-Share Competition of Anti-Ulcer Gastric Medications in the Ohio Medicaid Market. International Journal of Pharmaceutical Medicine. 18(5). 271–282. 9 indexed citations
10.
Heaton, Pamela C., Robert J. Cluxton, & Charles J. Moomaw. (2003). Acetaminophen Overuse in the Ohio Medicaid Population. Journal of the American Pharmacists Association. 43(6). 680–684. 11 indexed citations
11.
Johnston, Joseph A., Robert J. Cluxton, Pamela C. Heaton, et al.. (2003). Predictors of Warfarin Use Among Ohio Medicaid Patients With New-Onset Nonvalvular Atrial Fibrillation. Archives of Internal Medicine. 163(14). 1705–1705. 58 indexed citations
12.
Shireman, Theresa I., et al.. (2002). Relationship Between Asthma Drug Therapy Patterns and Healthcare Utilization. Annals of Pharmacotherapy. 36. 557–564. 1 indexed citations
13.
Rosen, Jules, et al.. (1993). As-Needed Dosing of Antipsychotic Drugs: Limitations and Guidelines for Use in the Elderly Agitated Patient. Annals of Pharmacotherapy. 27(5). 645–648. 8 indexed citations
14.
Cluxton, Robert J., et al.. (1988). Ursodiol: A Cholesterol Gallstone Solubilizing Agent. Drug Intelligence & Clinical Pharmacy. 22(12). 941–945. 3 indexed citations
15.
Pruemer, Jane M., et al.. (1988). Carboplatin: A New Cisplatin Analog. Drug Intelligence & Clinical Pharmacy. 22(11). 843–849. 21 indexed citations
16.
Cluxton, Robert J., et al.. (1987). Astemizole: A Long-Acting, Nonsedating Antihistamine. Drug Intelligence & Clinical Pharmacy. 21(12). 947–953. 20 indexed citations
17.
Cluxton, Robert J., et al.. (1987). The new black magic: Activated charcoal and new therapeutic uses. Journal of Emergency Medicine. 5(1). 9–18. 15 indexed citations
18.
Ritschel, W. A., et al.. (1981). Salivary Elimination of Cyclophosphamide in Man. The Journal of Clinical Pharmacology. 21(11). 461–465. 5 indexed citations
19.
Cluxton, Robert J.. (1980). Practical Drug Therapy. American Journal of Health-System Pharmacy. 37(4). 579–579. 2 indexed citations
20.
Cluxton, Robert J.. (1971). Some Complexities of Making Compatibility Studies in Hyperalimentation Solutions. Drug Intelligence & Clinical Pharmacy. 5(6). 177–180. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026